| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Apogee Therapeutics, Inc. | Director | Pre-Funded Warrants (Right to Buy) | 365,853 | $14,999,936 | $41.00 | 10 Oct 2025 | Indirect |
| Apogee Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14,461 | 17 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | 10 Oct 2025 | 1 | +$14,999,936 | 4 | Director | 15 Oct 2025, 16:10 |
| APGE | Apogee Therapeutics, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 20 Jun 2025, 20:05 |
| APGE | Apogee Therapeutics, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 20:02 |
| APGE | Apogee Therapeutics, Inc. | 13 Jul 2023 | 2 | +$29,750,000 | 4 | Director | 17 Jul 2023, 20:00 |
| APGE | Apogee Therapeutics, Inc. | 13 Jul 2023 | 0 | $0 | 3 | Director | 13 Jul 2023, 18:39 |